The Princess Alexandra Hospital is a 1133 bed tertiary referral hospital located in Brisbane, Australia.  The hospital provides care in all major adult specialties, except for obstetrics.  The hospital is recognised for its expertise in trauma management, cancer care, cardiac care and rehabilitation medicine.  It is one of Australia’s busiest surgical hospital and a major transplant centre.

The Princess Alexandra Hospital is a leading academic and research centre through its associated university partners and the Translation Research Institute.

The hospital made a significant investment in building capability to support its digital hospital program and became a fully digital hospital in early 2017.  It now utilises the complete functionality of the Integrated Electronic Medical Record (ieMR) and related digital hospital systems. This has facilitated a fundamental move to the organisation providing high reliability care to patients.

Being a digital hospital has enabled the service to deliver more effective and efficient health care with improved safety and quality. It is achieving measurable benefits through the innovative use of information technology, and the optimisation of processes and practices in clinical, operational and administrative functions.

In hospital was awarded Electronic Medical Record Adoption Model recognition by the international Healthcare Information and Management Systems Society. This milestone recognised the hospital as having established clear goals for improving safety, minimising errors, and prioritising the introduction of an ieMR.

The hospital is part of Metro South Hospital and Health Service which provides health care to a population of approximately 1.1 million people. All the hospitals in the Metro South area have subsequently become digital hospitals. This means that when a patient presents to any hospital in the Metro South area, their electronic medical record will be available to the medical staff at that hospital.

The presentation will discuss the drivers for the change, the challenges experienced in delivering on the hospitals digital roadmap, the benefits realised and the lessons learned along the way.

As a rapid emerging interdisciplinary field, the science of big data is playing a disruptive role in many sectors in recent years. The application of big data science is considered as strategically important to many established sectors of science and business world.

The big-data has the unique advantage in capturing the trend and formulating the national strategies.  Medicine, as a vital important variable of social development, should serve as the backbone of big data science. But for a very long time, medical data have been isolated in various medical institutions. The development of real-world medical big data has stagnated due to the difficult access to data. Without the integration with real-world big medical data, it is hard to achieve precision medicine only based genomic data research. In the world arena, even in the developed countries, such as the United States, the real-world big medical data is difficult to achieve due to the segmentation of healthcare system. In China, the large population, universal coverage of national Medicare system and strong government/policy leverage provides a unique opportunity for China to lead the development of science of big data in medicine. In this report, the essential characteristics of big data in medicine will be elaborated with real-world shown cases, which will focus on the current situation and future development of science and application of big data in medicine in China.

The UK’s National Health Service (NHS) Long Term Plan puts digital solutions at the forefront of its new transformation plan – through data, analytics, AI, cloud computing and mobile. New models of care, new clinical pathways and new patient tools are helping the NHS plan, manage and deliver safer and more efficient services for an ageing population and for rising disease prevalence across diabetes, obesity and mental health. As a single payer system, the NHS looks to innovators and accelerators from the international health community and from the SME marketplace to help deliver digital solutions and to expand our insights into clinical and patient adoption. Current priorities lie in prevention, well-being, population health management and in the faster diagnosis and treatment of cancer , mental health and cardio-vascular disease burdens.